Thromb Haemost 2002; 88(06): 1026-1032
DOI: 10.1055/s-0037-1613350
Involvement of Thrombin Receptors in the Subject-dependent Variability in Ca2+ Signal Generation
Schattauer GmbH

A Novel Hemizygous Bernard-Soulier Syndrome (BSS) Mutation in the Amino Terminal Domain of Glycoprotein (GP)Ibβ- Platelet Characterization and Transfection Studies

Andrew Hillmann
3   Department of Clinical Pharmacology, Royal College of Surgeons in Ireland, Dublin, Ireland
,
Alan Nurden
1   UMR 5533 CNRS, Hôpital Cardiologique, Pessac, France
,
Paquita Nurden
1   UMR 5533 CNRS, Hôpital Cardiologique, Pessac, France
,
Robert Combrié
1   UMR 5533 CNRS, Hôpital Cardiologique, Pessac, France
,
Ségolène Claeyssens
2   Centre Regional de l’Hémophilie, Hôpital Purpan, Toulouse, France
,
Niamh Moran
3   Department of Clinical Pharmacology, Royal College of Surgeons in Ireland, Dublin, Ireland
,
Dermot Kenny
3   Department of Clinical Pharmacology, Royal College of Surgeons in Ireland, Dublin, Ireland
› Author Affiliations
This work was supported by the Higher Education Authority of Ireland, Enterprise Ireland, the Irish Heart Foundation, and RCSI
Further Information

Publication History

Received 28 March 2002

Accepted after revision 29 July 2002

Publication Date:
09 December 2017 (online)

Summary

Glycoprotein (GP) Ib-V-IX is a unique adhesion receptor complex on platelets. Mutations in GPIbα, Ibβ, and IX can lead to the rare bleeding disorder, Bernard-Soulier Syndrome (BSS). Here, we report a novel hemizygous variant of BSS in which Pro29 in one GPIbβ allele is substituted by a Leu (GPIbβ:P29L). Fluoresence in situ hybridisation revealed that the 22q11 locus was deleted from the homologous chromosome. The pedigree was determined and revealed inheritance of the GPIbβ:P29L allele from the father. Flow cytometry with a range of antibodies detected no expression of GPIb-V-IX on the surface of the patient’s platelets. Western blotting revealed an absence of GPIbα and GPIbβ from platelet lysates. Co-expression of GPIbβ:P29L with normal GPIbα and GPIX in a heterologous cell system confirmed that the mutant subunit did not support surface expression of the complex. Interestingly, residual expression of GPIbβ:P29L anchored in the plasma membrane alone was now seen. This novel BSS mutation expressed in heterologous cells is in agreement with recent in vitro evidence that the correct conformation of the amino terminal region of GPIbβ is required for normal expression of the intact receptor complex.

 
  • References

  • 1 Nurden AT, Caen JP. Specific roles for platelet surface glycoproteins in platelet function. Nature 1975; 255: 720-2.
  • 2 Savage B, Saldivar E, Ruggeri ZM. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell 1996; 84: 289-97.
  • 3 Savage B, Sixma JJ, Ruggeri ZM. Functional self-association of von Willebrand factor during platelet adhesion under flow. Proc Natl Acad Sci USA 2002; 99: 425-30.
  • 4 Fredrickson BJ, Dong J-F, McIntire LV, López JA. Shear-Dependent Rolling on von Willebrand Factor of Mammalian Cells Expressing the Platelet Glycoprotein Ib-IX-V Complex. Blood 1998; 92: 3684-93.
  • 5 López JA, Andrews RK, Afshar-Kharghan V, Berndt MC. Bernard-Soulier syndrome. Blood 1998; 91: 4397-418.
  • 6 Wenger RH, Kieffer N, Wicki AN, Clemetson KJ. Structure of the human blood platelet membrane glycoprotein Ib alpha gene. Biochem Biophys Res Commun 1988; 156: 389-95.
  • 7 Yagi M, Edelhoff S, Disteche CM, Roth GJ. Structural characterization and chromosomal location of the gene encoding human platelet glycoprotein Ib beta. J Biol Chem 1994; 269: 17424-7.
  • 8 Hickey MJ, Deaven LL, Roth GJ. Human platelet glycoprotein IX. Characterization of cDNA and localization of the gene to chromosome 3. FEBS Lett 1990; 274: 189-92.
  • 9 Lanza F, Morales M, de La Salle C, Cazenave JP, Clemetson KJ, Shimomura T, Phillips DR. Cloning and characterization of the gene encoding the human platelet glycoprotein V. A member of the leucine-rich glycoprotein family cleaved during thrombin-induced platelet activation. J Biol Chem 1993; 268: 20801-7.
  • 10 López JA, Weisman S, Sanan DA, Sih T, Chambers M, Li CQ. Glycoprotein (GP) Ib beta is the critical subunit linking GP Ib alpha and GP IX in the GP Ib-IX complex. Analysis of partial complexes. J Biol Chem 1994; 269: 23716-21.
  • 11 López JA, Chung DW, Fujikawa K, Hagen FS, Davie EW, Roth GJ. The alpha and beta chains of human platelet glycoprotein Ib are both transmembrane proteins containing a leucine-rich amino acid sequence. Proc Natl Acad Sci USA 1988; 85: 2135-9.
  • 12 Du X, Beutler L, Ruan C, Castaldi PA, Berndt MC. Glycoprotein Ib and glycoprotein IX are fully complexed in the intact platelet membrane. Blood 1987; 69: 1524-7.
  • 13 Berndt MC, Gregory C, Kabral A, Zola H, Fournier D, Castaldi PA. Purification and preliminary characterization of the glycoprotein Ib complex in the human platelet membrane. Eur J Biochem 1985; 151: 637-49.
  • 14 Modderman PW, Admiraal LG, Sonnenberg A, von dem Borne AE. Glycoproteins V and Ib-IX form a noncovalent complex in the platelet membrane. J Biol Chem 1992; 267: 364-9.
  • 15 López JA. The platelet glycoprotein Ib-IX complex. Blood Coagul Fibrinolysis 1994; 05: 97-119.
  • 16 Poujol C, Ramakrishnan V, DeGuzman F, Nurden AT, Phillips DR, Nurden P. Ultrastructural analysis of megakaryocytes in GPV knockout mice. Thromb Haemost 2000; 84: 312-8.
  • 17 López JA, Weisman S, Sih T, Li CQ, Sanan DA. Association of GP Ib with actin-binding protein does not require GP IX. Blood Coagul Fibrinolysis 1994; 05: 479-85.
  • 18 López J, Leung B, Reynolds C, Li C, Fox J. Efficient plasma membrane expression of a functional platelet glycoprotein Ib-IX complex requires the presence of its three subunits. J Biol Chem 1992; 267: 12851-9.
  • 19 Dong J-f, Gao S, López JA. Synthesis, Assembly, and Intracellular Transport of the Platelet Glycoprotein Ib-IX-V Complex. J Biol Chem 1998; 273: 31449-54.
  • 20 Berndt MC, Shen Y, Dopheide SM, Gardiner EE, Andrews RK. The vascular biology of the glycoprotein Ib-IX-V complex. Thromb Haemost 2001; 86: 178-88.
  • 21 Sae-Tung G, Dong JF, López JA. Biosynthetic defect in platelet glycoprotein IX mutants associated with Bernard-Soulier syndrome. Blood 1996; 87: 1361-7.
  • 22 Kenny D, Morateck PA, Gill JC, Montgomery RR. The Critical Interaction of Glycoprotein (GP) Ibbeta with GPIX→A Genetic Cause of Bernard-Soulier Syndrome. Blood 1999; 93: 2968-75.
  • 23 Kenny D, Morateck PA, Montgomery RR. The cysteine knot of platelet glycoprotein Ibbeta (GPIbbeta ) is critical for the interaction of GPIbbeta with GPIX. Blood 2002; 99: 4428-33.
  • 24 Cuneo BF. 22q11.2 deletion syndrome: DiGeorge, velocardiofacial, and conotruncal anomaly face syndromes. Curr Opin Pediatr 2001; 13: 465-72.
  • 25 Hourdille P, Pico M, Jandrot-Perrus M, Lacaze D, Lozano M, Nurden AT. Studies on the megakaryocytes of a patient with the Bernard-Soulier syndrome. Br J Haematol 1990; 76: 521-30.
  • 26 Bihour C, Durrieu-Jais C, Macchi L, Poujol C, Coste P, Besse P, Nurden P, Nurden AT. Expression of markers of platelet activation and the interpatient variation in response to abciximab. Arterioscler Thromb Vasc Biol 1999; 19: 212-9.
  • 27 Ruan J, Schmugge M, Clemetson KJ, Cazes E, Combrie R, Bourre F, Nurden AT. Homozygous Cys542→Arg substitution in GPIIIa in a Swiss patient with type I Glanzmann’s thrombasthenia. Br J Haematol 1999; 105: 523-31.
  • 28 Budarf ML, Konkle BA, Ludlow LB, Michaud D, Li M, Yamashiro DJ, McDonald-McGinn D, Zackai EH, Driscoll DA. Identification of a patient with Bernard-Soulier syndrome and a deletion in the DiGeorge/velo-cardio-facial chromosomal region in 22q11.2. Hum Mol Genet 1995; 04: 763-6.
  • 29 DuBridge RB, Tang P, Hsia HC, Leong PM, Miller JH, Calos MP. Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol Cell Biol 1987; 07: 379-87.
  • 30 Kunishima S, López JA, Kobayashi S, Imai N, Kamiya T, Saito H, Naoe T. Missense Mutations of the Glycoprotein (GP) Ibbeta Gene Impairing the GPIb alpha /beta Disulfide Linkage in a Family With Giant Platelet Disorder. Blood 1997; 89: 2404-12.
  • 31 Kenny D, Newman PJ, Morateck PA, Montgomery RR. A dinucleotide deletion results in defective membrane anchoring and circulating soluble glycoprotein Ib alpha in a novel form of Bernard-Soulier syndrome. Blood 1997; 90: 2626-33.
  • 32 Moran N, Morateck PA, Deering A, Ryan M, Montgomery RR, Fitzgerald DJ, Kenny D. Surface expression of glycoprotein Ib alpha is dependent on glycoprotein Ib beta: evidence from a novel mutation causing Bernard- Soulier syndrome. Blood 2000; 96: 532-9.
  • 33 Ludlow LB, Schick BP, Budarf ML, Driscoll DA, Zackai EH, Cohen A, Konkle BA. Identification of a mutation in a GATA binding site of the platelet glycoprotein Ibbeta promoter resulting in the Bernard-Soulier syndrome. J Biol Chem 1996; 271: 22076-80.
  • 34 Perkins JA, Sie K, Gray S. Presence of 22q11 deletion in postadenoidectomy velopharyngeal insufficiency. Arch Otolaryngol Head Neck Surg 2000; 126: 645-8.
  • 35 Ulsemer P, Strassel C, Baas MJ, Salamero J, Chasserot-Golaz S, Cazenave JP, De La Salle C, Lanza F. Biosynthesis and intracellular post-translational processing of normal and mutant platelet glycoprotein GPIb-IX. Biochem J 2001; 358: 295-303.
  • 36 Kunishima S, Naoe T, Kamiya T, Saito H. Novel heterozygous missense mutation in the platelet glycoprotein Ib beta gene associated with isolated giant platelet disorder. Am J Hematol 2001; 68: 249-55.